StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.08−0.27 (-20.00%)

Close on Nov 18, 2026Market cap $33.96MP/E 3.0Yield –

Actinium Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Actinium Pharmaceuticals's total debt was $900.00K at Dec 31, 2019. For fiscal 2019 it was $900.00K.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$900.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$900.00K–
Q3 FY2019Sep 30, 2019$100.00K–
Q2 FY2019Jun 30, 2019$300.00K–
Q1 FY2019Mar 31, 2019$200.00K–

More Actinium Pharmaceuticals figures

See a number that looks wrong?